Recanalization of Chronic Total Occlusions in Patients With Previous Coronary Bypass Surgery and Consideration of Retrograde Access via Saphenous Vein Grafts
- PMID: 27418611
- DOI: 10.1161/CIRCINTERVENTIONS.115.003515
Recanalization of Chronic Total Occlusions in Patients With Previous Coronary Bypass Surgery and Consideration of Retrograde Access via Saphenous Vein Grafts
Abstract
Background: The prevalence of native coronary chronic total occlusions (CTOs) after coronary artery bypass grafts (CABGs) is higher than in non-CABG population. We examined outcomes of CTO percutaneous coronary intervention (PCI) post-CABG versus without CABG. Then, we looked at feasibility and outcomes of retrograde CTO PCI via patent or occluded saphenous vein graft.
Methods and results: We compared patient and procedural characteristics of 470 CTO cases treated from January 2010 to December 2015 depending on history of CABG. We assessed major adverse cardiac events, including cardiac death, myocardial infarction, ischemia-driven target-vessel revascularization, or reocclusion 1 year after successful CTO PCI in patients treated before February 2015. Post-CABG patients (175 cases) had a higher J-CTO score (2.5 versus 2.1; P=0.002). In-hospital complications were similar, although the incidence of contrast-induced nephropathy was higher in post-CABG patients (4.6% versus 1%; P=0.01). With multivariable analysis, post-CABG status was associated with higher incidence of 1-year major adverse cardiac event (hazards ratio=2.2; P=0.02). As a second level analysis, we looked at the feasibility and safety of CTO PCI via saphenous vein grafts (19% of post-CABG cases) versus collateral channels (36%) versus with an antegrade-only approach (45%), and assessed short-term outcomes and complications. High success was achieved in the saphenous vein graft group. In-hospital events were similar in the 3 groups.
Conclusions: Post-CABG CTO PCI is associated with similar high success and low complications compared with CTO PCI in patients who never had CABG. However, it is associated with higher recurrent events at 1 year. To achieve high success rate, use of saphenous vein grafts as retrograde conduits seems to be safe and effective.
Keywords: aortocoronary bypass; coronary occlusion; percutaneous coronary intervention.
© 2016 American Heart Association, Inc.
Similar articles
-
Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via Saphenous Vein Graft.JACC Cardiovasc Interv. 2020 Feb 24;13(4):517-526. doi: 10.1016/j.jcin.2019.10.028. JACC Cardiovasc Interv. 2020. PMID: 32081243
-
Long-Term Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients Who Have Undergone Coronary Artery Bypass Grafting vs Those Who Have Not.Can J Cardiol. 2018 Mar;34(3):310-318. doi: 10.1016/j.cjca.2017.12.016. Epub 2017 Dec 26. Can J Cardiol. 2018. PMID: 29395703
-
Use of Saphenous Vein Bypass Grafts for Retrograde Recanalization of Coronary Chronic Total Occlusions: Insights From a Multicenter Registry.J Invasive Cardiol. 2016 Jun;28(6):218-24. J Invasive Cardiol. 2016. PMID: 27236005
-
Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies.JACC Cardiovasc Interv. 2013 Feb;6(2):128-36. doi: 10.1016/j.jcin.2012.10.011. Epub 2013 Jan 23. JACC Cardiovasc Interv. 2013. PMID: 23352817 Review.
-
Outcomes with retrograde versus antegrade chronic total occlusion revascularization.Catheter Cardiovasc Interv. 2020 Nov;96(5):1037-1043. doi: 10.1002/ccd.28616. Epub 2019 Nov 28. Catheter Cardiovasc Interv. 2020. PMID: 31778041
Cited by
-
Retrograde CTO-PCI Using an Internal Thoracic Bypass Graft Segment in a Patient with Acute Inferior ST-Elevation Myocardial Infarction and Cardiogenic Shock.Int Med Case Rep J. 2022 Sep 15;15:499-505. doi: 10.2147/IMCRJ.S370231. eCollection 2022. Int Med Case Rep J. 2022. PMID: 36134250 Free PMC article.
-
Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial.Lancet. 2018 May 19;391(10134):1997-2007. doi: 10.1016/S0140-6736(18)30801-8. Epub 2018 May 11. Lancet. 2018. PMID: 29759512 Free PMC article. Clinical Trial.
-
Coronary Artery Bypass: Review of Surgical Techniques and Impact on Long-Term Revascularization Outcomes.Cardiol Ther. 2021 Jun;10(1):89-109. doi: 10.1007/s40119-021-00211-z. Epub 2021 Jan 30. Cardiol Ther. 2021. PMID: 33515370 Free PMC article. Review.
-
Stingray-ADR technique creating a channel between double CTO lesions in a previous CABG patient.BMC Cardiovasc Disord. 2025 May 6;25(1):351. doi: 10.1186/s12872-025-04799-1. BMC Cardiovasc Disord. 2025. PMID: 40329192 Free PMC article.
-
Advances in the Post-coronary Artery Bypass Graft Management of Occlusive Coronary Artery Disease.Interv Cardiol. 2021 Dec 24;16:e33. doi: 10.15420/icr.2021.12. eCollection 2021 Apr. Interv Cardiol. 2021. PMID: 35106069 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous